Insider Stock Trading History of Lovejoy Chandra D


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Lovejoy Chandra D since year 2005. The trader's CIK number is 1509420. At the time of this reporting, Lovejoy Chandra D is the SVP of Reg. Affairs & Quality of Pronai Therapeutics Inc . (stock ticker symbol DNAI). See this page for all insider trading activities at Pronai Therapeutics Inc .

Note that in the past Lovejoy Chandra D also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Lovejoy Chandra D since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2016-01-12 DNAI Pronai Therapeutics Inc Option Ex 7,551 .97 7,316
2016-01-12 DNAI Pronai Therapeutics Inc Sale 20,973 11.50 241,105
2014-08-11 ECYT Endocyte Inc Option Ex 21,479 3.30 70,988
2014-08-11 ECYT Endocyte Inc Sale 21,479 7.00 150,353
2013-08-06 ECYT Endocyte Inc Option Ex 7,000 2.71 18,970
2013-08-06 ECYT Endocyte Inc Sale 7,000 17.29 121,030
2013-02-25 ECYT Endocyte Inc Option Ex 2,102 2.80 5,875
2013-02-25 ECYT Endocyte Inc Sale 2,102 9.70 20,389
2013-01-25 ECYT Endocyte Inc Sale 2,209 9.56 21,118
2013-01-25 ECYT Endocyte Inc Option Ex 2,209 2.71 5,986
2012-12-26 ECYT Endocyte Inc Option Ex 2,209 2.54 5,610
2012-12-26 ECYT Endocyte Inc Sale 2,209 9.05 19,991
2012-11-26 ECYT Endocyte Inc Option Ex 2,209 2.54 5,610
2012-11-26 ECYT Endocyte Inc Sale 2,209 8.72 19,262
2012-10-25 ECYT Endocyte Inc Option Ex 2,209 2.54 5,610
2012-10-25 ECYT Endocyte Inc Sale 2,209 9.71 21,449
2012-09-25 ECYT Endocyte Inc Option Ex 2,209 2.54 5,610
2012-09-25 ECYT Endocyte Inc Sale 2,209 10.28 22,708

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Lovejoy Chandra D (SVP of Reg. Affairs & Quality of Pronai Therapeutics Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.